Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms

Mark D. Lesher; Cory M. Hale; Dona S.S. Wijetunge; Matt R. England; Debra S. Myers; David W. Craft

doi:10.1017/ice.2020.46

Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms

Mark D. Lesher, Cory M. Hale, Dona S.S. Wijetunge, Matt R. England, Debra S. Myers, David W. Craft

Department of Pathology and Laboratory Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

We characterized the impact of removal of the ESBL designation from microbiology reports on inpatient antibiotic prescribing. Definitive prescribing of carbapenems decreased from 48.4% to 16.1% (P =.01) and β-lactam-β-lactamase inhibitor combination increased from 19.4% to 61.3% (P =.002). Our findings confirm the importance of collaboration between microbiology and antimicrobial stewardship programs.

Original language	English (US)
Pages (from-to)	604-607
Number of pages	4
Journal	Infection Control and Hospital Epidemiology
Volume	41
Issue number	5
DOIs	https://doi.org/10.1017/ice.2020.46
State	Published - May 1 2020

All Science Journal Classification (ASJC) codes

Epidemiology
Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/ice.2020.46

Cite this

@article{254d39e166c94b57b7c354a3f094169a,

title = "Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms",

abstract = "We characterized the impact of removal of the ESBL designation from microbiology reports on inpatient antibiotic prescribing. Definitive prescribing of carbapenems decreased from 48.4% to 16.1% (P =.01) and β-lactam-β-lactamase inhibitor combination increased from 19.4% to 61.3% (P =.002). Our findings confirm the importance of collaboration between microbiology and antimicrobial stewardship programs.",

author = "Lesher, {Mark D.} and Hale, {Cory M.} and Wijetunge, {Dona S.S.} and England, {Matt R.} and Myers, {Debra S.} and Craft, {David W.}",

year = "2020",

month = may,

day = "1",

doi = "10.1017/ice.2020.46",

language = "English (US)",

volume = "41",

pages = "604--607",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "Cambridge University Press",

number = "5",

}

Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms. / Lesher, Mark D.; Hale, Cory M.; Wijetunge, Dona S.S. et al.
In: Infection Control and Hospital Epidemiology, Vol. 41, No. 5, 01.05.2020, p. 604-607.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms

AU - Lesher, Mark D.

AU - Hale, Cory M.

AU - Wijetunge, Dona S.S.

AU - England, Matt R.

AU - Myers, Debra S.

AU - Craft, David W.

PY - 2020/5/1

Y1 - 2020/5/1

N2 - We characterized the impact of removal of the ESBL designation from microbiology reports on inpatient antibiotic prescribing. Definitive prescribing of carbapenems decreased from 48.4% to 16.1% (P =.01) and β-lactam-β-lactamase inhibitor combination increased from 19.4% to 61.3% (P =.002). Our findings confirm the importance of collaboration between microbiology and antimicrobial stewardship programs.

AB - We characterized the impact of removal of the ESBL designation from microbiology reports on inpatient antibiotic prescribing. Definitive prescribing of carbapenems decreased from 48.4% to 16.1% (P =.01) and β-lactam-β-lactamase inhibitor combination increased from 19.4% to 61.3% (P =.002). Our findings confirm the importance of collaboration between microbiology and antimicrobial stewardship programs.

UR - http://www.scopus.com/inward/record.url?scp=85083245801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083245801&partnerID=8YFLogxK

U2 - 10.1017/ice.2020.46

DO - 10.1017/ice.2020.46

M3 - Article

C2 - 32248863

AN - SCOPUS:85083245801

SN - 0899-823X

VL - 41

SP - 604

EP - 607

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

IS - 5

ER -

Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this